Correlation Between Crispr Therapeutics and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Crispr Therapeutics and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Regeneron Pharmaceuticals.
Diversification Opportunities for Crispr Therapeutics and Regeneron Pharmaceuticals
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Crispr and Regeneron is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Regeneron Pharmaceuticals
Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 2.45 times more return on investment than Regeneron Pharmaceuticals. However, Crispr Therapeutics is 2.45 times more volatile than Regeneron Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 4,996 in Crispr Therapeutics AG on October 20, 2024 and sell it today you would lose (943.00) from holding Crispr Therapeutics AG or give up 18.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Regeneron Pharmaceuticals
Performance |
| Timeline |
| Crispr Therapeutics |
| Regeneron Pharmaceuticals |
Crispr Therapeutics and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Regeneron Pharmaceuticals
The main advantage of trading using opposite Crispr Therapeutics and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |